Sentinel node biopsy in melanoma

Virchows Archiv

Volumn 438, Issue 2, 2001, Pages 99-106

  Hauschild, Axel ^a   Christophers, Enno ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Lymphadenectomy; Melanoma; Metastasis; RT PCR; Sentinel node

Indexed keywords

CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; WORLD HEALTH ORGANIZATION;

ANTIGENS, NEOPLASM; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035117479     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000346     Document Type: Review

References (72)

1. Cutaneous melanoma
2. Primary therapy of malignant melanomas: Sentinel lymphadenectomy
3. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
4. A new American joint committee on cancer staging system for cutaneous melanoma
5. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
6. S100 protein in oral biology and pathology
7. Universal application of intraoperative lymphatic mapping and sentinel lymphad-enectomy in solid neoplasms
8. Lymph node micrometastases of cutaneous melanoma: Increased sensitivity of molecular diagnosis in comparison to immunohistochemistry
9. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin
10. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma
11. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients
12. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins
13. Hematogenous spread of malignant melanoma cells in different stages of disease
14. An approach for the treatment of penile carcinoma
15. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. WHO Melanoma Programme
16. Nodal nevi and cutaneous melanomas
17. Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin
18. S-100 protein as a marker for melanocytic and other tumors
19. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study
20. The pathologist's role in sentinel lymph node evaluation
21. Sentinel node biopsy in early vulva cancer
22. Standardized probe-directed sentinel node dissection in melanoma
23. Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society
24. S100 protein is present in cultured human malignant melanomas
25. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
26. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
27. Minimally invasive staging of patients with melanoma: Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction
28. Randomized trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
29. MAGE-3 immuno-reactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution
30. A rational approach to the surgical management of melanoma
31. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
32. Sentinel node biopsy for melanoma in the head and neck region
33. Immunohistochemistry and sentinel node biopsy in melanoma: The use of tyrosinase and melan-A
34. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
35. Sentinel node biopsy before and after wide excision of the primary melanoma
36. Sentinel lymphadenectomy in thyroid malignant neoplasms
37. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
38. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
39. Cancer statistics, 1998
40. Pathologic analysis of sentinel lymph nodes in breast carcinoma
41. Detection of melanoma micro-metastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction
42. The tumor biology of melanoma nodal metastases
43. Technical details of intraoperative lymphatic mapping for early stage melanoma
44. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial
45. The concept of sentinel node localization: How it started
46. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application
47. Cancer statistics, 1996
48. Adjuvant interferon alpha-2a treatment in resected primary stage II cutaneous melanoma
49. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression
50. The orderly progression of melanoma nodal metastases
51. Nevus cell aggregates associated with lymph nodes: Estimated frequency and clinical significance
52. Sentinel lymph-node biopsy in melanoma: Is less surgery better?
53. Surgical treatment of primary melanoma, 3rd edn
54. Amplification of Melan A messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma
55. HMB-45: A specific marker for melanoma metastases in the central nervous system?
56. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study
57. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
58. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: Sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas
59. Sentinel node localization in primary melanoma: Learning curve and results
60. Location of sentinel lymph nodes in patients with cutaneous melanoma: New insights into lymphatic anatomy
61. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology
62. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma
63. Variability of cutaneous lymphatic flow rates in melanoma patients
64. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients
65. Sentinel node biopsies in melanoma patients: A protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR
66. Immunohistochemical localization of S100 beta in human nervous system tumors by using monoclonal antibodies with specificity for the S100 beta polypeptide
67. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs
68. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
69. Applicability of the sentinel node technique to Merkel cell carcinoma
70. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: A multicenter study
71. Studies on significance of sentinel lymphadenectomy in pharyngeal and laryngeal carcinoma
72. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors